INFLUENZA

This is an early-stage study to test the safety and immune response of a new mRNA flu vaccine in healthy adults. Up to 50 participants, aged 18-49, will receive two doses of the experimental vaccine or one dose of a standard flu shot for comparison. The main goal is to see if the…

This study is testing a new type of flu vaccine called OVX836. It aims to provide broader protection against many different flu strains, not just the few selected each year. The trial involves 2,850 healthy adults aged 18-59 who will receive either the vaccine or a placebo shot. …

This study aims to check the safety of a new four-strain flu vaccine that includes an ingredient to boost the immune response. It will involve 80 healthy adults aged 65 and older. Researchers will closely monitor participants for any side effects or reactions for up to a year aft…

This study is testing the safety of a new flu vaccine designed for people aged 65 and older. It will enroll 80 healthy older adults to see how their bodies react to the shot. The main goal is to check for any side effects or safety issues over a year after vaccination.

This study aims to understand how a nasal spray flu vaccine triggers immune responses in the body. Researchers will give the vaccine to 60 healthy teenagers and collect blood and nasal samples to measure immune reactions. The goal is to learn how protection develops in both the b…

This study is testing different doses of an experimental oral drug called TRX-100, given alongside standard flu care. The goal is to find a safe and effective dose that helps reduce flu symptoms like cough, sore throat, and fever. Researchers will enroll 105 otherwise healthy adu…

This study is testing new, non-invasive devices that work like advanced electronic stethoscopes. The goal is to see if these devices, which listen to sounds and vibrations from a person's body, can accurately detect COVID-19, flu, and RSV infections. Researchers will compare the …

This study aims to find the best flu shot strategy for adults who recently received a kidney, heart, or liver transplant. Researchers are comparing stronger, high-dose flu shots to standard ones, and testing whether getting two shots in one season is better than one. The goal is …

This study is testing whether a new long-acting antiviral drug called CD388 can prevent the flu in adults and adolescents who are at higher risk of serious complications. Participants receive either the drug or a placebo as three small injections under the skin. The main goal is …

This study aims to find out which types of text message reminders are most effective at encouraging people to get their annual flu vaccine. It involves 100,000 patients who haven't yet received their shot. Researchers will test different message styles to see which one leads to t…

This study is exploring whether eating more fiber-rich foods can change the bacteria in your gut and improve how well your body responds to the flu vaccine. Researchers are testing two different high-fiber diets with a small group of healthy adults. The main goal is to see if peo…

This study aims to understand how a baby's first encounter with the flu—whether through infection or vaccination—shapes their immune system's response to future flu exposures. Researchers will follow 1,500 mother-infant pairs from pregnancy through early childhood, tracking illne…

This study aims to understand if a person's diet and the community of microbes (like bacteria) living in their gut are linked to how well their body responds to the seasonal flu vaccine. Researchers are enrolling 74 adult employees at MD Anderson Cancer Center who are getting the…

This study aims to understand how COVID-19 and influenza symptoms affect people's daily lives and health over time. It will follow 999 adults in the US who test positive for either virus and report having symptoms. Participants will fill out surveys about their symptoms, work, an…

This study is testing a home smell test kit to see if it can reliably track how people's sense of smell recovers after a COVID-19 infection. Researchers will send smell cards to 1,000 participants, including people who lost their smell from COVID, healthy people, and those with o…